WILD-TYPE ALTERNATIVELY SPLICED P53 - BINDING TO DNA AND INTERACTION WITH THE MAJOR P53 PROTEIN IN-VITRO AND IN CELLS

被引:55
|
作者
WU, Y [1 ]
LIU, YG [1 ]
LEE, L [1 ]
MINER, Z [1 ]
KULESZMARTIN, M [1 ]
机构
[1] ROSWELL PK CANC INST, DEPT EXPTL THERAPEUT, BUFFALO, NY 14263 USA
来源
EMBO JOURNAL | 1994年 / 13卷 / 20期
关键词
ALTERNATIVE SPLICING; DNA BINDING; WILD-TYPE P53 PROTEIN;
D O I
10.1002/j.1460-2075.1994.tb06808.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A p53 variant protein (p53as) generated from alternatively spliced p53 RNA is expressed in normal and malignant mouse cells and tissues, and p53as antigen activity is preferentially associated with the Gz phase of the cell cycle, suggesting that p53as and p53 protein may have distinct properties. Using p53as and p53 proteins translated bl vitro, we now provide evidence that p53as protein has efficient sequence-specific DNA-binding ability. DNA binding by p53 protein is inefficient in comparison and requires activation. Furthermore, p53as and p53 proteins formed hetero-oligomers when co-translated in vitro, resulting in inactivation of p53as DNA-binding activity. Gel filtration indicated that p53as translated in vitro, like p53, formed tetramers. In support of a functional role of p53as in cells, p53as/p53 hetero-oligomers were coimmunoprecipitated from mouse cells, and both protein forms were detectable in nuclear extracts by electrophoretic mobility shift assays. These results suggest that the biochemical functions of p53 are mediated by interaction between two endogenous protein products of the wild-type p53 gene.
引用
收藏
页码:4823 / 4830
页数:8
相关论文
共 50 条
  • [41] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Peixiang Li
    Thuy Bui
    Dawn Gray
    Henry J. Klamut
    Breast Cancer Research and Treatment, 1998, 48 : 273 - 286
  • [42] The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
    Li, Dan-Dan
    Sun, Ting
    Wu, Xiao-Qi
    Chen, Shu-Peng
    Deng, Rong
    Jiang, Shan
    Feng, Gong-Kan
    Pan, Jing-Xuan
    Zhang, Xiao-Shi
    Zeng, Yi-Xin
    Zhu, Xiao-Feng
    PLOS ONE, 2012, 7 (09):
  • [43] Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
    De Smet, Frederik
    Rubio, Mirian Saiz
    Hompes, Daphne
    Naus, Evelyne
    De Baets, Greet
    Langenberg, Tobias
    Hipp, Mark S.
    Houben, Bert
    Claes, Filip
    Charbonneau, Sarah
    Blanco, Javier Delgado
    Plaisance, Stephane
    Ramkissoon, Shakti
    Ramkissoon, Lori
    Simons, Colinda
    van den Brandt, Piet
    Weijenberg, Matty
    Van England, Manon
    Lambrechts, Sandrina
    Amant, Frederic
    D'Hoore, Andre
    Ligon, Keith L.
    Sagaert, Xavier
    Schymkowitz, Joost
    Rousseau, Frederic
    JOURNAL OF PATHOLOGY, 2017, 242 (01): : 24 - 38
  • [44] Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
    Moore, Lynette
    Lu, Xiongbin
    Ghebranious, Nader
    Tyner, Stuart
    Donehower, Lawrence A.
    MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (11-12) : 717 - 730
  • [45] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    Palacios, G.
    Moll, U. M.
    ONCOGENE, 2006, 25 (45) : 6133 - 6139
  • [46] Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53
    Milczarek, GJ
    Chen, WX
    Gupta, A
    Martinez, JD
    Bowden, GT
    CARCINOGENESIS, 1999, 20 (06) : 1043 - 1048
  • [47] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    G Palacios
    U M Moll
    Oncogene, 2006, 25 : 6133 - 6139
  • [48] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [49] p53 gene status predicts response of epithelial cells to wild-type p53.
    St John, LS
    Sauter, ER
    Herlyn, M
    Litwin, S
    Alder-Storthz, K
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 167 - 167
  • [50] Requirement of wild-type p53 protein for maintenance of chromosomal integrity
    Honma, M
    Momose, M
    Tanabe, H
    Sakamoto, H
    Yu, YJ
    Little, JB
    Sofuni, T
    Hayashi, W
    MOLECULAR CARCINOGENESIS, 2000, 28 (04) : 203 - 214